Archive · 20 Nov 2025
Ultrahuman Secures ₹100 Crore in Venture Debt for Global Expansion
Ultrahuman, a health-tech company, got ₹100 crore to expand globally.
They've grown a lot and want to keep growing without giving up too much ownership.
They're having a small fight with another company about their smart ring, but it's not a big problem right now.
Ultrahuman raises ₹100 crore in venture debt from Alteria Capital
Funds to support expansion in Canada, Mexico, and Australia
Company's revenue grew 5x in FY25, reaching ₹580 crore
US revenue share decreasing as other markets grow
Patent dispute with Oura limited to smart ring category
- Who
- Ultrahuman, Alteria Capital
- What
- Raised ₹100 crore in venture debt
- When
- Recently
- Where
- Globally, including Canada, Mexico, and Australia
- Why
- To support rapid expansion and avoid diluting equity
Ultrahuman's Perspective
Oura's Perspective
Patent Dispute Impact
Ultrahuman's Perspective
Limited to ring category, no revenue impact in FY26
Oura's Perspective
Not explicitly stated in the article
- Revenue Growth
- 5x in FY25, 16x over two years
- Current Revenue
- ₹580 crore in FY25
- US Revenue Share
- 40%, expected to drop to 25%
- Patent Dispute
- Limited to smart ring category
- Revenue Impact
- No impact expected in FY26
- Revenue Projection
- ₹1,000 crore in FY26